Towards a Pragmatic Approach to a Psychophysiological Unit of Analysis for Mental and Brain Disorders: An EEG-Copeia for Neurofeedback

Micoulaud-Franchi, Jean-Arthur; Batail, Jean-Marie; Fovet, Thomas; Philip, Pierre; Cermolacce, M.; Jaumard-Hakoun, Aurore; Vialatte, François

doi:10.1007/s10484-019-09440-4

Cited by 15 publications

(14 citation statements)

References 300 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most neurofeedback training paradigms are informed by neurophysiological or computational models suggested to explain the genesis of depressive symptoms. Thereby, this technique provides potentially a new way to directly test for the causal validity of reported biomarkers (Mehler and Kording, 2018;Micoulaud-Franchi et al, 2019). Similar to brain stimulation protocols (e.g.…”

Section: Rationale For the Use Of Neurofeedback For Mddmentioning

confidence: 99%

Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices

Trambaiolli

Linden

Mehler

2021

Neuroscience & Biobehavioral Reviews

View full text Add to dashboard Cite

Major depressive disorder (MDD) is the leading cause of disability worldwide. Neurofeedback training has been suggested as a potential additional treatment option for MDD patients not reaching remission from standard care (i.e., psychopharmacology and psychotherapy). Here we systematically reviewed neurofeedback studies employing electroencephalography, or functional magnetic resonance-based protocols in depressive patients. Of 585 initially screened studies, 24 were included in our final sample (N=480 patients in experimental and N=194 in the control groups completing the primary endpoint). We evaluated the clinical efficacy across studies and explored its relationship with the number of sessions as a potential proxy for a dose-effect response. We also attempted to group studies according to the control condition categories currently used in the field that affect clinical outcomes in group comparisons. In most studies, MDD patients showed symptom improvement superior to the control group(s). However, most articles did not comply with the most stringent study quality and reporting practices. We conclude with recommendations on best practices for experimental designs and reporting standards for neurofeedback training.

show abstract

Section: Rationale For the Use Of Neurofeedback For Mddmentioning

confidence: 99%

Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices

Trambaiolli

Linden

Mehler

2021

Neuroscience & Biobehavioral Reviews

View full text Add to dashboard Cite

show abstract

“…For example, patients with MCI and AD present altered EEG frequencies (Cassani et al, 2018) and abnormal fMRI functional connectivity at rest (Jacobs et al, 2013;Badhwar et al, 2017). These correlates may provide biomarkers, and their predictive potential as well as validity can be tested by using these as treatment targets (Micoulaud-Franchi et al, 2019;Mehler and Kording, 2018). Similar to brain stimulation protocols, neurofeedback protocols aim to modulate local activity (Linden, 2014).…”

Section: Neurofeedback and The Aging Brainmentioning

confidence: 99%

Neurofeedback and the aging brain: a systematic review of training protocols for dementia and mild cognitive impairment

Trambaiolli¹,

Cassani²,

Mehler³

et al. 2021

Preprint

View full text Add to dashboard Cite

Dementia describes a set of symptoms that occur in neurodegenerative disorders and that is characterized by gradual loss of cognitive and behavioral functions. Recently, non-invasive neurofeedback training has been explored as a potential complementary treatment for patients suffering from dementia or mild cognitive impairment. Here we systematically reviewed studies that explored neurofeedback training protocols based on electroencephalography or functional magnetic resonance imaging for these groups of patients. From a total of 1,912 screened studies, 10 were included in our final sample (N=208 independent participants in experimental and N=81 in the control groups completing the primary endpoint). We compared the clinical efficacy across studies, and evaluated their experimental designs and reporting quality. In most studies, patients showed improved scores in different cognitive tests. However, data from randomized controlled trials remains scarce, and clinical evidence based on standardized metrics is still inconclusive. In light of recent meta-research developments in the neurofeedback field and beyond, quality and reporting practices of individual studies are reviewed. We conclude with recommendations on best practices for future studies that investigate the effects of neurofeedback training in dementia and cognitive impairment.

show abstract

“…Most neurofeedback training paradigms are informed by neurophysiological or computational models suggested to underly symptoms of depression. Thereby, this technique provides potentially a new way to directly test for potential causal validity of reported biomarkers [61,62]. Similar to brain stimulation protocols such as TMS or DBS [63], most neurofeedback protocols aim to modulate local activity.…”

Section: Rationale For the Use Of Neurofeedback For Mddmentioning

confidence: 99%

Neurofeedback training in major depressive disorder: a systematic review of clinical efficacy, study quality and reporting practices

Trambaiolli¹,

Linden²,

Mehler³

2020

Preprint

View full text Add to dashboard Cite

Major depressive disorder (MDD) is the leading cause of disability worldwide. Neurofeedback training has been suggested as a potential additional treatment option for MDD patients not reaching remission from psychopharmacology and psychotherapy. Here we systematically reviewed neurofeedback studies employing electroencephalography, or functional magnetic resonance-based protocols in depressive patients. From a total of 585 screened studies, 24 were included in our final sample (N=480 patients in experimental and N=194 in the control groups completing the primary endpoint). We evaluated the clinical efficacy across studies and explored its relationship with the number of sessions as a potential proxy for a dose-effect response. We also attempted to group studies according to the control condition categories currently used in the field that affect clinical outcomes in group comparisons. In most studies, MDD patients showed symptom improvement superior to the control group(s). However, most articles did not comply with the most stringent study quality and reporting practices. We conclude with recommendations on best practices for experimental designs and reporting standards for neurofeedback training.

show abstract

Towards a Pragmatic Approach to a Psychophysiological Unit of Analysis for Mental and Brain Disorders: An EEG-Copeia for Neurofeedback

Cited by 15 publications

References 300 publications

Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices

Neurofeedback training in major depressive disorder: A systematic review of clinical efficacy, study quality and reporting practices

Neurofeedback and the aging brain: a systematic review of training protocols for dementia and mild cognitive impairment

Neurofeedback training in major depressive disorder: a systematic review of clinical efficacy, study quality and reporting practices

Contact Info

Product

Resources

About